Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
GIP: Glucose-Dependent Insulinotropic Peptide
This study is ongoing, but not recruiting participants.
Study NCT00239707 Information provided by National Institute on Aging (NIA)
First Received: October 13, 2005 Last Updated: August 28, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type 2 Diabetes
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Modified GIP (GIP analog)
Normal Saline
Additional drug interventions recognized in this trial
Gastric Inhibitory Polypeptide
More general drug interventions related to this trial
Gastrointestinal Agents
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Incretins
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute on Aging (NIA)
Back to top of Main Content